BPC-157 vs GHK-Cu at a glance
| BPC-157 | GHK-Cu | |
|---|---|---|
| Also known as | Body Protection Compound 157 | Copper Peptide |
| Category | Healing & Recovery | Healing & Recovery |
| Format | SubQ | SubQ |
| Research level | Beginner | Beginner |
| Research sizes | 5 mg vial, 10 mg vial | 50 mg vial, 100 mg vial |
| In one line | A pentadecapeptide widely studied for tendon, ligament, and gut-tissue repair. | A copper-binding tripeptide studied for skin, hair, and tissue-regeneration research. |
What is BPC-157?
BPC-157 (Body Protection Compound 157) is a synthetic, stable pentadecapeptide of 15 amino acids derived from a partial sequence of a protein found in human gastric juice. In the research literature it is one of the most frequently studied "body protection" peptides because of its stability in gastric and aqueous environments and its broad activity across connective and epithelial tissue models.
Research models associate BPC-157 with up-regulation of growth-factor signaling (notably the VEGFR2 pathway and FAK-paxillin signaling) that supports angiogenesis - the formation of new blood vessels - in injured tissue. It is also studied for modulation of the nitric-oxide system and for interaction with the gut-brain axis. These mechanisms are the subject of ongoing pre-clinical investigation and are reported in animal and in-vitro studies, not approved clinical indications.
What is GHK-Cu?
GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine bound to copper). It is one of the most studied peptides in regenerative and dermatological research because of its role in copper transport and remodeling of the extracellular matrix.
Research associates GHK-Cu with stimulation of collagen and elastin synthesis, antioxidant and anti-inflammatory signaling, and modulation of genes involved in tissue remodeling. The injectable form is studied separately from topical cosmetic applications.
Key research differences
The two are best understood by what each is studied for. BPC-157: Compared with TB-500, BPC-157 is studied as a faster-acting, more localized repair peptide; compared with GHK-Cu it targets connective and gut tissue rather than skin and hair. It is one of the most stability-tested peptides in the research catalog. GHK-Cu: GHK-Cu targets skin, hair, and matrix research where BPC-157 and TB-500 target connective and muscle tissue, so it covers a distinct research niche.
How researchers choose between them
Because BPC-157 and GHK-Cu both sit in the healing & recovery category, the choice is a research-design question: match the compound to the exact signal or endpoint your model targets, and in many protocols the two are studied in parallel or in sequence rather than as either/or. Whichever you select, compare on verified quality: both are third-party tested to a 99%+ purity target with a COA on request.
Frequently asked questions
What is the difference between BPC-157 and GHK-Cu?
BPC-157 a pentadecapeptide widely studied for tendon, ligament, and gut-tissue repair; GHK-Cu a copper-binding tripeptide studied for skin, hair, and tissue-regeneration research. Both are healing & recovery research peptides. Both are research-use-only.
Can BPC-157 and GHK-Cu be studied together?
Yes - within the same category they are often studied in parallel or sequence to compare or combine effects. Any combination work is laboratory research only.
Which is better, BPC-157 or GHK-Cu?
Neither is universally "better" - the right choice depends on the research question. Match the compound to your model's target signal, and compare suppliers on verifiable third-party purity, not sticker price.
All comparisons · BPC-157 · GHK-Cu · BPC-157 cost
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration